TRANSAMINITIS INDUCED BY EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR PREDICTS FOR FAVOURABLE OUTCOME IN EGFR MUTATION POSITIVE NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Ang, John Kay Hooi [1 ]
Jain, Amit [1 ]
Chan, Kian Sing [2 ]
Takano, Angela [3 ]
Lim, Tony Kiat Hon [3 ]
Ng, Quan-Sing [1 ]
Ang, Mei-Kim [1 ]
Oon, Lynette Lin Ean [2 ]
Lim, Wan-Teck [1 ]
Tan, Eng-Huat [1 ]
Tan, Daniel Shao Weng [1 ]
机构：
[1] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore
[2] Singapore Gen Hosp, Mol Lab, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
non-small cell lung cancer; tyrosine kinase inhibitors; transaminitis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-030
引用
收藏
页码：S608 / S609
页数：2
相关论文
共 50 条
  • [1] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [2] Uncommon mutation types of Epidermal Growth Factor Receptor (EGFR) and tyrosine kinase inhibitor response in non-small cell lung carcinoma
    Wong, Maria P.
    Lee, Victor H. F.
    Yeung, Rebecca M. W.
    Tin, Vicky P. C.
    Choy, Kit Chi
    Liu, Jing
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [3] First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation - Positive non-small cell lung cancer patients
    Sequist, Lecia V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S143 - S145
  • [4] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
  • [5] EGFR Tyrosine Kinase Inhibitor and Chemotherapy in EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Nishino, Kazumi
    Kimura, Madoka
    Inoue, Takako
    Uchida, Junji
    Kumagai, Toru
    Imamura, Fumio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [6] Tyrosine Kinase-Inhibitors effective in epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCL)
    Pommer, Peter
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (18) : 1284 - 1284
  • [7] Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer
    Noda, Shoko
    Kanda, Shintaro
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 547 - 556
  • [8] Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Gelatti, Ana C. Z.
    Drilon, Alexander
    Santini, Fernando C.
    [J]. LUNG CANCER, 2019, 137 : 113 - 122
  • [9] CYTOKERATIN 19 FRAGMENT (CYFRA 21-1) PREDICTS THE EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-TYROSINE KINASE INHIBITOR IN NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATION
    Kosuke, T.
    [J]. RESPIROLOGY, 2012, 17 : 83 - 83
  • [10] An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer
    Yoshimura, Akihiro
    Uchino, Junji
    Tanimura, Keiko
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Takeda, Takayuki
    Hiranuma, Osamu
    Hasegawa, Isao
    Kubota, Yutaka
    Shiotsu, Shinsuke
    Takumi, Chieko
    Hiraoka, Noriya
    Yamada, Tadaaki
    Takayama, Koichi
    [J]. MEDICINE, 2018, 97 (40)
12345